美光科技(MU.US)半導體廠動工 將公佈新廠投資計劃
格隆匯9月13日丨DRAM內存製造商美光科技(MU.US)首席執行官Sanjay Mehrotra表示,即將公佈投資計劃的新工廠,產品生產範圍涉及個人電腦、數據中心及其他設備。美光早前宣佈投資150億美元的新半導體工廠週一動土。Mehrotra稱,另一間新工廠的選址工作已進入最後階段,短期內將會作出公佈。美光科技指出,兩間新工廠均從事DRAM半導體生產,全面投入運作後,美國工廠生產的DRAM將佔全球產量四成,遠高於目前的一成。美光週一動土興建的新工廠預料2025年投入運作,是集團20年來首間美國生產廠房,預計創造2000個職位。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.